| Nome |
# |
|
Exergames for balance dysfunction in neurological disability: a meta-analysis with meta-regression, file e4233f17-a298-2860-e053-6605fe0a460a
|
83
|
|
Dual-calibrated fMRI measurement of absolute cerebral metabolic rate of oxygen consumption and effective oxygen diffusivity, file e4233f17-6bf8-2860-e053-6605fe0a460a
|
49
|
|
Comparing MRI metrics to quantify white matter microstructural damage in multiple sclerosis, file e4233f17-74a6-2860-e053-6605fe0a460a
|
33
|
|
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study, file e4233f17-6c2d-2860-e053-6605fe0a460a
|
29
|
|
Clinical Outcomes of Escalation vs Early Intensive Disease-Modifying Therapy in Patients with Multiple Sclerosis, file e4233f19-49a2-2860-e053-6605fe0a460a
|
28
|
|
How common is truly benign MS in a UK population?, file e4233f17-6bf9-2860-e053-6605fe0a460a
|
24
|
|
Sex hormones, brain damage and clinical course of Multiple Sclerosis, file ad48508f-2a6d-40be-af9d-153ed199062e
|
22
|
|
Neuroplasticity and motor rehabilitation in multiple sclerosis, file e4233f17-6c9d-2860-e053-6605fe0a460a
|
21
|
|
Tractography in the presence of multiple sclerosis lesions, file e4233f17-6c2b-2860-e053-6605fe0a460a
|
19
|
|
A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study, file e4233f17-6c38-2860-e053-6605fe0a460a
|
19
|
|
Relationship between Prolactin Plasma Levels and White Matter Volume in Women with Multiple Sclerosis, file e4233f17-6c3b-2860-e053-6605fe0a460a
|
19
|
|
A flow-diffusion model of oxygen transport for quantitative mapping of cerebral metabolic rate of oxygen (CMRO2) with single gas calibrated fMRI, file e4233f18-fb62-2860-e053-6605fe0a460a
|
18
|
|
Site-specific clinical disease onset in multiple sclerosis, file e4233f17-6ca3-2860-e053-6605fe0a460a
|
15
|
|
Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS, file e0111517-4c0b-455f-8b1f-4cc1a0ead953
|
14
|
|
Brain morphometry in Multiple Sclerosis, file e4233f17-6ca6-2860-e053-6605fe0a460a
|
14
|
|
Impaired Functional Connectivity Unmasked by Simple Repetitive Motor Task in Early Relapsing-Remitting Multiple Sclerosis, file e4233f17-751f-2860-e053-6605fe0a460a
|
14
|
|
Assessment of the Effects of Aerobic Fitness on Cerebrovascular Function in Young Adults Using Multiple Inversion Time Arterial Spin Labeling MRI, file e4233f17-9bee-2860-e053-6605fe0a460a
|
14
|
|
Diagnosis and management of multiple sclerosis: MRI in clinical practice, file e4233f18-42ae-2860-e053-6605fe0a460a
|
14
|
|
A 6-year clinical and MRI follow-up study of patients with relapsing-remitting multiple sclerosis treated with Interferon-beta, file cef8e516-b952-4c79-8482-e60de567d2fd
|
13
|
|
Oral contraceptives combined with interferon b in multiple sclerosis, file e4233f17-6c3d-2860-e053-6605fe0a460a
|
13
|
|
A frequency-domain machine learning method for dual-calibrated fMRI mapping of oxygen extraction fraction (OEF) and cerebral metabolic rate of oxygen consumption (CMRO 2), file e4233f18-2ee1-2860-e053-6605fe0a460a
|
13
|
|
Relating brain damage to brain plasticity in patients with multiple sclerosis, file cc6aaa09-e0a9-43a9-ab44-6892e2f2d6aa
|
12
|
|
Cerebral Metabolic Changes During Visuomotor Adaptation Assessed Using Quantitative fMRI, file e4233f18-9529-2860-e053-6605fe0a460a
|
11
|
|
Case Report: Multiple Sclerosis Relapses After Vaccination Against SARS-CoV2: A Series of Clinical Cases, file e4233f18-e6a2-2860-e053-6605fe0a460a
|
11
|
|
Clinical Outcomes of Escalation vs Early Intensive Disease-Modifying Therapy in Patients with Multiple Sclerosis, file e4233f17-d6e1-2860-e053-6605fe0a460a
|
10
|
|
Contribution of metabolomics to multiple sclerosis diagnosis, prognosis and treatment, file e4233f18-8afb-2860-e053-6605fe0a460a
|
10
|
|
Diffusion-Weighted Imaging Tractography-Based Parcellation of the Human Parietal Cortex and Comparison with Human and Macaque Resting-State Functional Connectivity, file 865ea25d-79e1-4e8b-8efa-475204649bc4
|
9
|
|
Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study, file cc0536a3-8408-4a30-8d7f-3e6148e96b2a
|
9
|
|
Effect on Cognition of Estroprogestins Combined with Interferon Beta in Multiple Sclerosis: Analysis of Secondary Outcomes from a Randomised Controlled Trial, file e4233f17-7514-2860-e053-6605fe0a460a
|
9
|
|
Predictors of training-related improvement in visuomotor performance in patients with multiple sclerosis: A behavioural and MRI study, file e4233f18-a606-2860-e053-6605fe0a460a
|
9
|
|
Medical education and MS: getting the training right, file ebc0c6b0-7911-4ff0-810a-c268fd2ace31
|
9
|
|
Preservation of motor skill learning in patients with multiple sclerosis, file ff2ed503-9775-4149-a593-0be464f920d8
|
9
|
|
Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study, file 91fc1129-0cea-48bd-ba5a-b130248c1af9
|
8
|
|
The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis, file ae612c8f-2b35-43b2-aaec-48ce8077f5e2
|
8
|
|
'Gender gap' in multiple sclerosis: magnetic resonance imaging evidence, file e4a38a0d-e8ab-4cdc-883c-d6e39eecb134
|
8
|
|
Neutralizing antibodies explain the poor clinical response to interferon beta in a small proportion of patients with multiple sclerosis: a retrospective study, file eaa92a3c-2341-4e94-a68f-81b4a74d4d5c
|
8
|
|
Motor practice promotes increased activity in brain regions structurally disconnected after subcortical stroke, file a1da467b-167f-4dcc-8115-2189f2a2a47a
|
7
|
|
Harmonization of real-world studies in multiple sclerosis: Retrospective analysis from the rirems group, file e4233f18-4283-2860-e053-6605fe0a460a
|
7
|
|
Mechanisms of Network Changes in Cognitive Impairment in Multiple Sclerosis, file e4233f19-409c-2860-e053-6605fe0a460a
|
7
|
|
Distinct and overlapping functional zones in the cerebellum defined by resting state functional connectivity, file 3a364204-6a1d-4181-92bf-5086791a4f5a
|
6
|
|
Age-related changes in grey and white matter structure throughout adulthood, file 5d9d4f0e-c11b-4e90-8986-5fe23c4e2459
|
6
|
|
Sex hormones modulate brain damage in multiple sclerosis: MRI evidence, file c2a798b1-fe3e-49c5-bcb7-3721e72e9194
|
6
|
|
Cerebrovascular reactivity in multiple sclerosis is restored with reduced inflammation during immunomodulation, file c6488013-02ac-400b-8ce7-63feb54c06f0
|
6
|
|
Similarities and differences between multiple sclerosis and type 1 diabetes, file e4233f18-ecf4-2860-e053-6605fe0a460a
|
6
|
|
A tractometry principal component analysis of white matter tract network structure and relationships with cognitive function in relapsing-remitting multiple sclerosis, file 169d1671-b2a4-4bbd-9a29-3cc4c4a440f3
|
5
|
|
Guillain–Barré syndrome and COVID-19 vaccination: a systematic review and meta-analysis, file b504b25f-c3ab-4204-925f-d98bffd5a71b
|
5
|
|
Corrigendum: A Frequency-Domain Machine Learning Method for Dual-Calibrated fMRI Mapping of Oxygen Extraction Fraction (OEF) and Cerebral Metabolic Rate of Oxygen Consumption (CMRO 2), file e4233f19-409e-2860-e053-6605fe0a460a
|
5
|
|
Breath-hold BOLD fMRI without CO2 sampling enables estimation of venous cerebral blood volume: potential use in normalization of stimulus-evoked BOLD fMRI data, file 5aa225cc-64b0-4fab-9185-9d0fdb564f14
|
4
|
|
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study, file e4233f17-74a4-2860-e053-6605fe0a460a
|
4
|
|
Guillain−Barré syndrome and SARS-CoV-2 infection: a systematic review and meta-analysis on a debated issue and evidence for the ‘Italian factor’, file 6f6b91a5-b280-43ba-beb8-7e5246ec64cb
|
3
|
|
The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis, file 7f0443f2-2ee8-4032-b431-d50c900709eb
|
3
|
|
SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose, file 7f7608b5-bfd7-4326-a273-870fe9d83bdd
|
3
|
|
Evidence of impaired brain activity balance after passive sensorimotor stimulation in multiple sclerosis, file d18d0217-10f8-49e5-a529-e1dfc9cffde1
|
3
|
|
The effect of inflammation and its reduction on brain plasticity in multiple sclerosis: MRI evidence, file e4233f17-7516-2860-e053-6605fe0a460a
|
3
|
|
Relationship between emotional distress in caregivers and health status in persons with multiple sclerosis, file fcf61df5-4e05-429e-a414-89bd814e7059
|
3
|
|
Sex hormones: a role in the control of multiple sclerosis?, file 238f8d2e-5e58-4e26-97e9-9976be528708
|
2
|
|
Monthly corticosteroids decrease neutralizing antibodies to IFNbeta1 b: a randomized trial in multiple sclerosis, file 957b0b86-445a-48bb-be34-e857a4237dc5
|
2
|
|
Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial, file 9618c566-af5e-4dba-b35b-2be001d74698
|
2
|
|
Changes in brain perfusion with training-related visuomotor improvement in MS, file a7897655-6e63-40e3-82f9-a9d4cd6fa6e1
|
2
|
|
Neutralizing and binding antibodies to IFN-beta: relative frequency in relapsing-remitting multiple sclerosis patients treated with different IFN-beta preparations, file b4cf97d6-5036-4a84-88d9-fab2374447b9
|
2
|
|
Fate of neutralizing and binding antibodies to IFN beta in MS patients treated with IFN beta for 6 years, file b89f2da6-02a4-46e5-8913-9bbcad96e2cc
|
2
|
|
Informing MS patients on treatment options: a consensus on the process of consent taking, file e4233f17-a1d1-2860-e053-6605fe0a460a
|
2
|
|
Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study, file e4233f18-5b36-2860-e053-6605fe0a460a
|
2
|
|
A multicenter survey on access to care in Multiple Sclerosis-related trigeminal neuralgia, file e4233f18-ecf7-2860-e053-6605fe0a460a
|
2
|
|
Contemporary study of multiple sclerosis disability in South East Wales, file ee33115e-8341-436c-bc4f-7285b72d4a1f
|
2
|
|
Interferon beta treatment of MS in the daily clinical setting: a 3-year post-marketing study, file 09030899-dabb-4d1d-8a4e-eefe7dbd73ad
|
1
|
|
Multiple sclerosis lesions: insights from imaging techniques, file 2b6a966f-c0d3-41e7-897e-5b2778accea2
|
1
|
|
Brain atrophy in relapsing-remitting multiple sclerosis: relationship with 'black holes', disease duration and clinical disability, file 2d38e8c7-1da8-4c75-8bfb-ef54cc787649
|
1
|
|
Post-marketing survey on clinical response to interferon beta in relapsing multiple sclerosis: the Roman experience, file 36070d1a-c1b1-478d-a63b-93dfd45985b4
|
1
|
|
Model-free characterization of brain functional networks for motor sequence learning using fMRI, file 56182585-1baf-46e9-9938-6bf112ae1b90
|
1
|
|
Alexithymia in multiple sclerosis: relationship with fatigue and depression, file 58fe297e-0003-433c-b266-935607f88779
|
1
|
|
Reduced brain oxygen metabolism in patients with multiple sclerosis: Evidence from dual-calibrated functional MRI, file 6070c432-eb5d-468a-bc31-b506dc25a815
|
1
|
|
Pathophysiology of multiple sclerosis damage and repair: Linking cerebral hypoperfusion to the development of irreversible tissue loss in multiple sclerosis using magnetic resonance imaging, file 67c19a1b-a092-4276-ad04-ee7e59d030d6
|
1
|
|
Neuroplasticity and functional recovery in multiple sclerosis, file 88500a3a-d5a0-42c8-84f6-44e3e5228788
|
1
|
|
Structural and functional bases for individual differences in motor learning, file 9097840a-cfb1-4419-9ba3-f4175d9a0c73
|
1
|
|
Predictors of long-term clinical response to interferon beta therapy in relapsing multiple sclerosis, file 986ae154-aa8f-4a1c-aac4-d58b807aabfd
|
1
|
|
Diffusion-weighted imaging tractography-based parcellation of the human lateral premotor cortex identifies dorsal and ventral subregions with anatomical and functional specializations, file 9d35a13b-9f4a-457f-b1f8-bdd307469cde
|
1
|
|
Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment, file adc566c6-bc14-4534-b2ae-49ed717d09f3
|
1
|
|
Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study, file e24cf2a4-8482-4a8b-8d38-68316a9ead9f
|
1
|
|
Neurological update: MOG antibody disease, file e4233f17-6bf6-2860-e053-6605fe0a460a
|
1
|
|
Predicting the profile of increasing disability in multiple sclerosis, file e4233f17-6bfc-2860-e053-6605fe0a460a
|
1
|
|
Testosterone amplifies excitotoxic damage of cultured oligodendrocytes., file e4233f17-6ca4-2860-e053-6605fe0a460a
|
1
|
|
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study, file e4233f18-f1b0-2860-e053-6605fe0a460a
|
1
|
|
Cannabinoid-induced effects on the nociceptive system: a neurophysiological study in patients with secondary progressive multiple sclerosis, file ef9e5c22-de96-4c2d-9816-3a36b348173d
|
1
|
|
Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosis, file feaedea9-a218-43e4-8832-3f4740af2a74
|
1
|
| Totale |
760 |